Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on long-term anticoagulation therapy, suggests a major registry analysis. There was no significant difference in adjusted risk of bleeding or in a primary endpoint that included death and ischemic events whether